21-Chloro-9-fluoro-11-hydroxy-16-methyl-17-(1-oxopropoxy)pregna-1,4-diene-3,20-dione (11beta,16beta)-

ACCESS ALL DATA, CHEMISTRY

ACTIVE PHARMA INGREDIENTS

68 API Suppliers, 14 USDMF, 12 CEP/COS, 4 JDMF, 14 EU WC, 16 KDMF, 14 NDC API, 39 Listed Suppliers, $ API Reference Price

DEVELOPMENTS

44 Drugs in Development

44 Drugs in Development

FINISHED DOSAGE FORMULATIONS

267 FDF Dossiers, 100 FDA Orange Book, 94 Europe, 25 Canada, 3 Australia, 9 South Africa, 36 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CREAM;TOPICAL - 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, CREAM;TOPICAL - 0.025%, AEROSOL, FOAM;TOPICAL - 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**, LOTION;TOPICAL - 0.05%, LOTION;TOPICAL - 0.05%, SHAMPOO;TOPICAL - 0.05%, AEROSOL, FOAM;TOPICAL - 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI, 1 SPI Pharma, 1 Gangwal Healthcare, 8 Nanjing Well Pharmaceutical, 3 Kirsch Pharma, 4 Dr. Paul Lohmann GmbH & Co. KGaA, 1 ACG Worldwide, 9 Actylis, 1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd, 17 BASF, 2 CD Formulation, 1 Clariant, 14 Corel Pharma Chem, 1 Esteem Industries, 1 Finar, 9 Gangwal Chemicals, 2 Gloria Interchem, 3 Ideal Cures, 9 Kerry, 3 Kima Chemical, 6 Lonza Capsugel, 5 Lubrizol Life Science Health, 3 Microlex e.U, 1 Nanjing Bold Chemical, 1 Novo Excipients, 2 Pluviaendo, 1 Qianhao Chemical (Hebei) Co., Ltd, 1 Qualicaps, 18 Seppic, 1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd, 2 The Dow Chemical Company, 1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

42 Topical, 38 Coating Systems & Additives, 23 Solubilizers, 17 Thickeners and Stabilizers, 16 Controlled & Modified Release, 16 Parenteral, 15 Emulsifying Agents, 13 Surfactant & Foaming Agents, 11 Film Formers & Plasticizers, 8 API Stability Enhancers, 6 Granulation, 5 Empty Capsules, 5 Taste Masking, 5 Direct Compression, 4 Vegetarian Capsules, 4 Fillers, Diluents & Binders, 4 Rheology Modifiers, 3 Lubricants & Glidants, 2 Co-Processed Excipients, 2 Coloring Agents, 1 Disintegrants & Superdisintegrants, 1 Chewable & Orodispersible Aids

DIGITAL CONTENT

90 News #PharmaBuzz

90 News #PharmaBuzz

GLOBAL SALES INFORMATION

41 US Medicaid Prescriptions, 32 Regulatory FDF Prices

MARKET PLACE

27 APIs, 3 FDF Dossiers

PATENTS & EXCLUSIVITIES

17 US Patents, 1 US Exclusivities, 3 Health Canada Patents

REF. STANDARDS & IMPURITIES

3 EDQM, 1 JP, 4 Others

$ Xls

Filters

21-Chloro-9-fluoro-11-hydroxy-16-methyl-17-(1-oxopropoxy)pregna-1,4-diene-3,20-dione (11beta,16beta)-

Filters

FILTER :

filter Company Reset all filters

1 All

01 1Novo Excipients

filter Capability Reset all filters

filter Country Reset all filters

01

Novo Excipients

HYDROXYPROPYL METHYL CELLULOSE

ICMD China

Not Confirmed

Privacy policy
Terms and conditions
Disclaimers
Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

Looking for Pharmaceutical Excipients offered by Novo Excipients? Find 21-Chloro-9-fluoro-11-hydroxy-16-methyl-17-(1-oxopropoxy)pregna-1,4-diene-3,20-dione (11beta,16beta)- to address your drug delivery challenges on PharmaCompass.

21-Chloro-9-fluoro-11-hydroxy-16-methyl-17-(1-oxopropoxy)pregna-1,4-diene-3,20-dione (11beta,16beta)-

ACCESS ALL DATA

CHEMISTRY

Discover Molecule Insights

ACTIVE PHARMA INGREDIENTS

68 API Suppliers

14 USDMF

12 CEP/COS

4 JDMF

14 EU WC

16 KDMF

14 NDC API

39 Listed Suppliers

$ API Reference Price

DEVELOPMENTS

44 Drugs in Development

FINISHED DOSAGE FORMULATIONS

267 FDF Dossiers

100 FDA Orange Book

94 Europe

25 Canada

3 Australia

9 South Africa

36 Listed Dossiers

DRUG PRODUCT COMPOSITIONS

CREAM;TOPICAL - 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

CREAM;TOPICAL - 0.025%

AEROSOL, FOAM;TOPICAL - 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

LOTION;TOPICAL - 0.05%

LOTION;TOPICAL - 0.05%

SHAMPOO;TOPICAL - 0.05%

AEROSOL, FOAM;TOPICAL - 0.05% **Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons**

RELATED EXCIPIENT COMPANIES

2 EUROAPI

1 SPI Pharma

1 Gangwal Healthcare

8 Nanjing Well Pharmaceutical

3 Kirsch Pharma

4 Dr. Paul Lohmann GmbH & Co. KGaA

1 ACG Worldwide

9 Actylis

1 Anhui Sunhere Pharmaceutical Excipients Co.,Ltd

17 BASF

2 CD Formulation

1 Clariant

14 Corel Pharma Chem

1 Esteem Industries

1 Finar

9 Gangwal Chemicals

2 Gloria Interchem

3 Ideal Cures

9 Kerry

3 Kima Chemical

6 Lonza Capsugel

5 Lubrizol Life Science Health

3 Microlex e.U

1 Nanjing Bold Chemical

1 Novo Excipients

2 Pluviaendo

1 Qianhao Chemical (Hebei) Co., Ltd

1 Qualicaps

18 Seppic

1 Shanghai Shenmei Pharmaceutical Technology Co., Ltd

2 The Dow Chemical Company

1 Valens Pharmachem

EXCIPIENTS BY APPLICATIONS

42 Topical

38 Coating Systems & Additives

23 Solubilizers

17 Thickeners and Stabilizers

16 Controlled & Modified Release

16 Parenteral

15 Emulsifying Agents

13 Surfactant & Foaming Agents

11 Film Formers & Plasticizers

8 API Stability Enhancers

6 Granulation

5 Empty Capsules

5 Taste Masking

CREAM;TOPICAL - 0.05% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

AEROSOL, FOAM;TOPICAL - 0.05% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons

AEROSOL, FOAM;TOPICAL - 0.05% Federal Register determination that product was not discontinued or withdrawn for safety or effectiveness reasons